IP Library Granted Patent US 12,364,607
Granted Patent B2
US 12,364,607 · App. 16/898,796 · Granted Jul 22, 2025

Wound care device having dynamic bioactive nanofiber scaffolding

Inventors: Thomas E. Day (Rolla, MO); Steven B. Jung (Rolla, MO); Charanpreet S. Bagga (Basking Ridge, NJ)
A61F2/28A61L27/10A61L27/12A61L27/427A61L27/54A61L27/56A61L27/58A61F2002/2835A61F2210/0004A61F2210/0076A61L2430/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,364,607
App. No.
16/898,796
Granted
Jul 22, 2025
Kind
B2
Abstract

A resorbable bone graft scaffold material, including a plurality of overlapping and interlocking fibers defining a scaffold structure, plurality of pores distributed throughout the scaffold, and a plurality of glass microspheres distributed throughout the pores. The fibers are characterized by fiber diameters ranging from about 5 nanometers to about 100 micrometers, and the fibers are a bioactive, resorbable material. The fibers generally contribute about 20 to about 40 weight percent of the scaffold material, with the microspheres contributing the balance.

Claims (25)

1. A wound care device, comprising:

a porous, pliable and formable support matrix comprising a plurality of overlapping and entangled solid, polymer-free bioactive, resorbable ceramic fibers, each respective fiber having a diameter ranging from about 5 nanometers to about 100 micrometers;

a plurality of pores distributed throughout the support matrix; and

a plurality of bioactive, resorbable glass or ceramic beads distributed throughout the support matrix;

wherein the wound care device is configured to be sufficiently chemically durable to reduce or stop blood loss from the wound.

2. The wound care device of claim 1 , wherein the beads contribute about 60 weight percent and the fibers contribute about 40 weight percent of the support matrix,

further wherein the support matrix has a bulk density of greater than about 0.1 g/cc for blood treatment applications.

3. The wound care device of claim 1 , wherein the beads contribute about 90 weight percent and the fibers contribute about 10 weight percent of the support matrix,

further wherein the support matrix has a bulk density of greater than about 0.5 g/cc for blood treatment applications.

4. The wound care device of claim 1 , wherein the fibers are composed of a material selected from the group including calcium phosphate, hydroxyapatite, bioactive glass and combinations thereof.

5. The wound care device of claim 1 , wherein the beads are solid and wherein the beads have the same composition as the fibers.

6. The wound care device of claim 1 , further including a medicine, a nutritive supplement, an antibiotic, an antiviral, a vitamin, or a combination thereof.

7. The wound care device of claim 1 , wherein at least some of the respective beads are fused to at least one respective fiber.

8. The wound care device of claim 1 , wherein the fiber diameters are substantially between about 10 nanometers and about 10 micrometers.

9. The wound care device of claim 1 , wherein at least some of the fibers are fused together.

10. The wound care device of claim 1 , wherein the beads have diameters ranging from about 30 microns to about 3 millimeters.

11. The wound care device of claim 1 , further comprising a carrier.

12. The wound care device of claim 11 , wherein the carrier is selected from the group consisting of polaxamer, glycerol, alkaline oxide copolymers, and bone marrow aspirate.

13. The wound care device of claim 1 , wherein the fibers are randomly oriented with respect to each other.

14. The wound care device of claim 1 , wherein the fibers have varying diameters.

15. The wound care device of claim 1 , wherein at least some of the fibers are nanofibers.

16. The wound care device of claim 1 , wherein the beads have varying sizes.

17. The wound care device of claim 1 , wherein some of the fibers are fused to some of the beads.

18. The wound care device of claim 1 , wherein the fibers are interlinked to form a fibrous, self-constrained construct, some of the fibers being freely movable over other fibers of the construct.

19. The wound care device of claim 1 , further having a formed, regular shape including a sheet.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2022
From: BAGGA, CHARANPREET S.
To: MO-SCI CORPORATION
Reel/Frame 060116/0936 →
Continuity (6)
Continuation 16796263 · Feb 20, 2020
Continuation 15198057 · Jun 30, 2016
Continuation 13721724 · Dec 20, 2012
Continuation In Part 12437531 · May 7, 2009
Provisional Application 61127172 · May 12, 2008
Related Publication 20200297493A1 · Sep 24, 2020
References Cited (10)
US 5401693A · Bauer et al. · 1995 [cited by applicant]
US 5965125A · Mineau-Hanschke · 1999 [cited by applicant]
US 6416774B1 · Radin et al. · 2002 [cited by applicant]
US 6451059B1 · Janas et al. · 2002 [cited by applicant]
US 6517857B2 · Ylanen et al. · 2003 [cited by applicant]
US 7579077B2 · Dubrow et al. · 2009 [cited by applicant]
US 20050169967A1 · Gilchrist et al. · 2005 [cited by applicant]
US 20080292839A1 · Wei et al. · 2008 [cited by applicant]
US 20090060961A1 · Naruse et al. · 2009 [cited by applicant]
US 20110206828A1 · Liu et al. · 2011 [cited by applicant]